Changing Trends in Prostate Cancer Therapy: Is Earlier Better?
September 24th 2014
Although the incidence and mortality of prostate cancer remain formidable problems in the United States, clinicians have many new agents with proven overall survival (OS) benefits to recommend for patients with metastatic disease.